These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31390691)

  • 41. The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community.
    Alvarez GG; Van Dyk DD; Davies N; Aaron SD; Cameron DW; Desjardins M; Mallick R; Obed N; Baikie M
    PLoS One; 2014; 9(11):e111986. PubMed ID: 25386908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis.
    Campbell JR; Winters N; Menzies D
    BMJ; 2020 Mar; 368():m549. PubMed ID: 32156698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
    Kwakernaak AJ; Houtman PM; Weel JF; Spoorenberg JP; Jansen TL
    Clin Rheumatol; 2011 Apr; 30(4):505-10. PubMed ID: 20737179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia.
    Adetifa IM; Ota MO; Jeffries DJ; Hammond A; Lugos MD; Donkor S; Patrick O; Adegbola RA; Hill PC
    Pediatr Infect Dis J; 2010 May; 29(5):439-43. PubMed ID: 20068506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of Interferon-Gamma Release Assays in Children <2 Years Old.
    Turner NA; Ahmed A; Haley CA; Starke JR; Stout JE
    J Pediatric Infect Dis Soc; 2023 Aug; 12(8):481-485. PubMed ID: 37478309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts.
    Yoo JW; Jo KW; Park GY; Shim TS
    Respir Med; 2016 Feb; 111():77-83. PubMed ID: 26725461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tuberculosis screening prior to anti-tumor necrosis factor therapy among patients with immune-mediated inflammatory diseases in Japan: a longitudinal study using a large-scale health insurance claims database.
    Tomio J; Yamana H; Matsui H; Yamashita H; Yoshiyama T; Yasunaga H
    Int J Rheum Dis; 2017 Nov; 20(11):1674-1683. PubMed ID: 29076252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
    Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
    Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of IGRA and TST in the diagnosis of latent tuberculosis among women of reproductive age in South India.
    Prakash Babu S; Ezhumalai K; Raghupathy K; Sundaresan M; Jain K; Narasimhan PB; Knudsen S; Horsburgh CR; Hochberg NS; Salgame P; Ellner J; Sarkar S
    Indian J Tuberc; 2023 Jan; 70(1):12-16. PubMed ID: 36740307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia.
    Laemmle-Ruff I; Graham SM; Williams B; Horyniak D; Majumdar SS; Paxton GA; Soares Caplice LV; Hellard ME; Trauer JM
    Emerg Infect Dis; 2022 Sep; 28(9):1833-1841. PubMed ID: 35997353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.
    Chang B; Park HY; Jeon K; Ahn JK; Cha HS; Koh EM; Kang ES; Koh WJ
    Clin Rheumatol; 2011 Dec; 30(12):1535-41. PubMed ID: 21556777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.
    Pourakbari B; Yousefi K; Mahmoudi S; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2019; 19(2):141-144. PubMed ID: 29493468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil.
    Kussen GM; Dalla-Costa LM; Rossoni A; Raboni SM
    Braz J Infect Dis; 2016; 20(1):69-75. PubMed ID: 26706018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.
    Elzi L; Steffen I; Furrer H; Fehr J; Cavassini M; Hirschel B; Hoffmann M; Bernasconi E; Bassetti S; Battegay M
    BMC Infect Dis; 2011 Nov; 11():319. PubMed ID: 22085801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
    Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
    BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of tuberculin skin test and interferon gamma assay for the diagnosis of latent tuberculosis infection in juvenile idiopathic arthritis.
    Camlar SA; Makay B; Appak O; Appak YC; Esen N; Günay T; Anal O; Unsal E
    Clin Rheumatol; 2011 Sep; 30(9):1189-93. PubMed ID: 21403997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea.
    Hur YG; Hong JY; Choi DH; Kim A; Park SY; Kwon M; Kang K; Lee JM; Dockrell HM; Lee Y; Joo H; Cho SN
    Yonsei Med J; 2019 Apr; 60(4):375-380. PubMed ID: 30900424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.